KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Goodwill & Intangibles (2016 - 2025)

Historic Goodwill & Intangibles for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $19.8 billion.

  • Teva Pharmaceutical Industries' Goodwill & Intangibles rose 110.4% to $19.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $19.8 billion, marking a year-over-year increase of 110.4%. This contributed to the annual value of $19.8 billion for FY2025, which is 110.4% up from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Goodwill & Intangibles stood at $19.8 billion for Q4 2025, which was up 110.4% from $19.9 billion recorded in Q3 2025.
  • Teva Pharmaceutical Industries' Goodwill & Intangibles' 5-year high stood at $28.7 billion during Q1 2021, with a 5-year trough of $7.2 billion in Q2 2022.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $22.5 billion (2023), whereas its average is $22.4 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Goodwill & Intangibles tumbled by 7484.67% in 2022 and then skyrocketed by 21837.3% in 2023.
  • Teva Pharmaceutical Industries' Goodwill & Intangibles (Quarter) stood at $25.1 billion in 2021, then fell by 6.58% to $23.4 billion in 2022, then dropped by 3.77% to $22.6 billion in 2023, then decreased by 13.29% to $19.6 billion in 2024, then rose by 1.1% to $19.8 billion in 2025.
  • Its Goodwill & Intangibles was $19.8 billion in Q4 2025, compared to $19.9 billion in Q3 2025 and $20.1 billion in Q2 2025.